Sec. 3. Assessment regarding illicit fentanyl
249 words·~1 min read·
/bill/118/hr/3666/ih/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The head of the Office of National Drug Control Policy, in consultation with the heads of such other Federal agencies as the head of the Office of National Drug Control Policy deems appropriate, shall conduct an assessment of the following: Foreign manufacturing of illicit fentanyl. The tools and capabilities across Federal agencies to address trafficking of illicit fentanyl. How coordination of Federal efforts to address such trafficking can be improved, including identification of duplicative Federal efforts.
The capacities of the Mexican military to conduct counterdrug missions with respect to illicit fentanyl. The capacities and willingness of the People’s Republic of China to curtail the flow of illicit fentanyl, conduct inspections and investigations with respect to illicit fentanyl, screen for illicit fentanyl at ports of exit, implement know-your-customer standards, and hold traffickers of illicit fentanyl accountable. Illicit fentanyl being trafficked into the United States from Mexico, including the purity, formulation, and weight of the illicit fentanyl.
Not later than 180 days after the date of enactment of this Act, the head of the Office of National Drug Control Policy shall— complete the assessment required by subsection (a); and submit a report to the Congress on the results of such assessment. In this section, the term illicit fentanyl means fentanyl and any analogue or precursor thereof that is manufactured, distributed, or dispensed, or possessed with intent to manufacture, distribute, or dispense, in violation of section 401, 406, or 416 of the Controlled Substances Act ( 21 U.S.C. 841 , 846, 856).
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 3
Assessment regarding illicit fentanyl
Cites 1Cited by 0 across 0 sources